{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"0.118","rs_stock_flag":false,"fiscal_year_end":"2025年3月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"2,550,000,000","primaryexch":"香港交易所","ric":"0858.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"M","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0932,"inline_upper_strike_price":"","sedol":"6208110","am":"764.19","iv":"","ew_strike":"","as":"0.114","geographic_focus":null,"incorpin":"百慕達","etp_baseCur":null,"ew_amt_os":"","bd":"0.110","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"10,000","update_time":"2025-09-28 00:06:03.0","lo52":"0.030","shares_issued_date":"2025年9月10日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"謝毅","underlying_ric":"0858.HK","hi52":"0.149","issuer_name":"精優藥業控股有限公司","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日15:50","aum_date":"","lo":"0.102","mkt_cap":"290.70","f_aum_hkd":null,"ew_sub_per_to":"","ls":"0.114","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"+0.002","aum":"","issued_shares_class_B":null,"vo":"6.79","secondary_listing_flag":false,"listing_date":"1999年3月10日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"精優藥業控股有限公司","nm_s":"精優藥業","sym":"858","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.001","strike_price":"","summary":"精優藥業控股有限公司是一家主要從事開發、製造及銷售藥品的投資控股公司。該公司主要通過三個分部運營業務。製造分部從事醫藥產品的開發、製造及銷售業務。其自製產品包括轉移因子口服溶液、貫新克及洲邦等。貿易分部從事進口藥品的推廣及經銷業務。其進口產品包括美利巴及適今可。基因開發分部從事基因相關技術的商業開發及研發業務。","op":"0.118","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港鰂魚涌<br/>英皇道979號<br/>太古坊德宏大廈<br/>22樓2206-08室","pc":"+1.79","days_to_expiry":null,"underlying_code":null,"pe":"1.22","eps_ccy":"HKD","hdr":false,"launch_date":"","hc":"0.112","isin":"BMG3285Q1134","moneyness":""}},"qid":"1759074758723"}
